CN215536652U - Film coating structure - Google Patents

Film coating structure Download PDF

Info

Publication number
CN215536652U
CN215536652U CN202022846522.7U CN202022846522U CN215536652U CN 215536652 U CN215536652 U CN 215536652U CN 202022846522 U CN202022846522 U CN 202022846522U CN 215536652 U CN215536652 U CN 215536652U
Authority
CN
China
Prior art keywords
film
concave
convex
particles
thickness
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202022846522.7U
Other languages
Chinese (zh)
Inventor
朱万力
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Healthtake Corp
Original Assignee
Healthtake Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Healthtake Corp filed Critical Healthtake Corp
Priority to CN202022846522.7U priority Critical patent/CN215536652U/en
Application granted granted Critical
Publication of CN215536652U publication Critical patent/CN215536652U/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicinal Preparation (AREA)

Abstract

The utility model relates to a film coating structure, comprising: a core body including a plurality of irregularly shaped particles, a portion of the plurality of particles forming a concave-convex outer surface on an exterior side of the core body; and a film layer, including a concave-convex inner surface attached to the concave-convex outer surface, a plurality of first portions and a plurality of second portions with a thickness smaller than that of one of the first portions, at least one gap is enclosed between the concave-convex outer surface and the concave-convex inner surface, and each gap at least partially corresponds to one of the first portions. The film coating structure provided by the utility model can be stably formed.

Description

Film coating structure
Technical Field
The present invention relates to a coating structure, and more particularly to a film coating structure.
Background
The conventional coating structure, such as filling powder into capsules or coating a film on the outside of tablets, can achieve the effects of moisture resistance, beauty, odor resistance, storage stability improvement, etc. However, in the conventional coating structure, the film coating or capsule and the contents coated therein are not stably combined, and the thickness is large to be unfavorable for decomposition and absorption; in addition, the conventional tablet has a poor forming effect and is easily broken when being impacted, so that there is a disadvantage to be improved.
Therefore, there is a need to provide a novel and advanced film coating structure to solve the above problems.
SUMMERY OF THE UTILITY MODEL
The main object of the present invention is to provide a film coating structure which can be stably formed.
To achieve the above object, the present invention provides a film coating structure, comprising: a core body including a plurality of irregularly shaped particles, a portion of the plurality of particles forming a concave-convex outer surface on an exterior side of the core body; and a film layer, including a concave-convex inner surface attached to the concave-convex outer surface, a plurality of first portions and a plurality of second portions with a thickness smaller than that of one of the first portions, at least one gap is enclosed between the concave-convex outer surface and the concave-convex inner surface, and each gap at least partially corresponds to one of the first portions.
Preferably, the concave-convex outer surface includes a plurality of protruding portions, and the concave-convex inner surface includes a plurality of concave portions correspondingly attached to at least one of the protruding portions, each of the concave portions being provided at one of the second portions.
Preferably, the thickness of each first portion decreases in a direction toward a second portion.
Preferably, the plurality of first portions include at least one convex surface protruding toward one of the gaps.
Preferably, the core body has a maximum radial dimension of between 1.2 cm and 1.8 cm.
Preferably, the average thickness of the film layer is less than the radial dimension of at least a portion of the plurality of particles.
Preferably, the thickness of each second portion is 0.1 to 0.6 times the thickness of one of the first portions.
Preferably, the thickness of each first portion decreases towards the direction of one second portion; the plurality of first portions include at least one convex surface protruding toward the gap; the core body having a maximum radial dimension of between 1.2 cm and 1.8 cm; the average thickness of the film layer is smaller than the radial dimension of at least part of the plurality of particles; the thickness of each second part is 0.1 to 0.6 times of that of one first part; the film layer has a smooth outer surface; the core body comprises a ring peripheral surface and two end surfaces which are connected with two opposite sides of the ring peripheral surface in the circumferential direction, and each end surface is an arc convex surface; the film layer is a transparent layer; the plurality of particles has at least two colors.
The utility model has the advantages that:
the film coating structure provided by the utility model can be stably formed.
Drawings
Fig. 1 is a perspective view of a preferred embodiment of the present invention.
FIG. 2 is a cross-sectional view of a preferred embodiment of the present invention.
Fig. 3 is an enlarged view of the area a of fig. 2.
Fig. 4 is a partially enlarged view of fig. 3.
Detailed Description
The following description is given by way of example only, and is not intended to limit the scope of the utility model.
Referring to fig. 1-4, which illustrate a preferred embodiment of the present invention, a film-clad structure 1 of the present invention includes a core 10 and a film 20.
The core body 10 includes a plurality of irregularly shaped particles 11, a portion of the plurality of particles 11 forming a concave-convex outer surface 111 on an outer side of the core body 10; the film 20 includes a concave-convex inner surface 21 attached to the concave-convex outer surface 111, a plurality of first portions 22, and a plurality of second portions 23 having a thickness smaller than that of one of the first portions 22, at least one gap 30 is defined between the concave-convex outer surface 111 and the concave-convex inner surface 21, and each gap 30 at least partially corresponds to one of the first portions 22. Thus, the corners of each particle 11, the concave-convex outer surface 111 and the concave-convex inner surface 21 all contribute to the attachment of the membrane layer 20, the stability is good and the peeling is not easy, and when the membrane layer 20 is decomposed, the at least one gap 30 allows saliva to be easily attached to the outer surface of the core body 10, and the effective components are easily decomposed and released.
The concave-convex outer surface 111 comprises a plurality of protruding portions 112, the concave-convex inner surface 21 comprises a plurality of concave portions 211 correspondingly attached to at least one of the protruding portions 112, each concave portion 211 is arranged on one of the second portions 23, and the combination stability is good. With reference to fig. 3 and 4, the thickness T1 of each first portion 22 decreases toward the second portion 23; the plurality of first portions 22 include at least one convex surface 212 protruding toward one of the gaps 30. The first portion 22 of greater thickness thereby provides sufficient structural strength to prevent relative dislocation of the plurality of particles 11 on the surface of the core body 10, and the film 20 is of a relatively thin average thickness to facilitate disintegration.
In the present embodiment, the plurality of first portions 22 and the plurality of second portions 23 are staggered, so that the film layer 20 can be stably attached to the concave-convex outer surface 111; each of the second portions 23 having a thickness T2 of 0.1 to 0.6 times the thickness T1 of one of the first portions 22 and having a thickness differential suitable to stably engage the concave-convex outer surface 111 to render the core body 10 less susceptible to deterioration and easy storage; the film 20 is preferably a transparent layer and has a smooth outer surface, which is aesthetically pleasing and easy to swallow. The film 20 has an average thickness less than the radial dimension of at least a portion of the plurality of particles 11, and a thickness that facilitates disintegration.
The maximum radial dimension of the film coating structure 1 is 1.2 cm to 1.8 cm, so that the swallow is facilitated. In the embodiment, the film-cladding structure 1 further includes a circumferential surface 40 and two end surfaces 50 circumferentially connected to two opposite sides of the circumferential surface 40, each end surface 50 is an arc convex surface, and the contact area is large to facilitate decomposition; the maximum radial dimension of the film-coated structure 1 is 1.5 mm and the height is 7 mm. However, each end surface can also be a plane or an arc concave surface, and the film coating structure can also be configured into other specification sizes according to requirements.
The plurality of granules 11 include at least one of Garcinia cambogia extract granules, green coffee bean extract granules, mulberry leaf extract granules, and Undaria pinnatifida extract granules. The component of the Garcinia cambogia extract granule comprises Hydroxycitric Acid (HCA) having a structure similar to that of citric Acid, and thus has the effects of inhibiting the Activity of Citrate Lyase (ACLY) and reducing fatty Acid synthesis. The green coffee bean extract granule contains Chlorogenic Acid (Chlorogenic Acid) which inhibits fat absorption and stimulates fat cell metabolism in the liver. The folium Mori extract granule contains 1-Deoxynojirimycin (DNJ), Phytosterol (Phytosterol), and Flavonoids (Flavonoids), and has effects of reducing blood lipid, blood glucose, triglyceride in blood, and total cholesterol. The Undaria pinnatifida extract granule comprises alginic acid (Sodium Alginate), Fucoidan (Fucoidan) and trace elements, has high nutritive value, and is beneficial to reducing blood sugar and blood ester. Preferably, the plurality of particles 11 further comprise chromium yeast particles, which provide beneficial regulation and improvement of lipid metabolism.
Further, the radial size of the Garcinia cambogia extract particles is between 20 and 60 mesh; the green coffee bean extract particles have a radial size of between 20 to 60 mesh; the mulberry leaf extract particles have a radial size of 20 to 60 mesh; the radial size of the undaria pinnatifida extract particles is 60 to 100 meshes; the yeast chromium particles have a radial size of 40 to 80 mesh. In this embodiment, the radial sizes of the Garcinia cambogia extract particles, the green coffee bean extract particles and the mulberry leaf extract particles are all 40 mesh, the radial size of the Undaria pinnatifida extract particles is 80 mesh, and the radial size of the yeast chromium particles is 60 mesh, which can be uniformly mixed and embedded with each other by the difference of the radial sizes to have a stable and compact structure. However, the plurality of particles may be arranged in other radial dimensions as desired.
Preferably, the plurality of particles 11 have at least two colors; for example, the green coffee bean extract particles and the undaria pinnatifida extract particles are black particles, and the yeast chromium particles are yellow particles, which have a colorful appearance and show a visual effect of mixing various components therein.
In order to evaluate the efficacy of the present invention, animal experiments were conducted according to the specification of "evaluation method of fat function of health food which is not easy to form body" announced by the ministry of health and welfare affairs in taiwan.
The experiment was randomly grouped using 60 six week old male Sprague-Dawley rats, 12 rats per group. The experimental groups included: one control group (given general feed 2.85Kcal/g) and four experimental groups (given high calorie feed 5.24 Kcal/g). The experimental groups were tube fed with 0.5% carboxymethyl cellulose (CMC), 1-fold, 2-fold and 4-fold doses of the membrane-coated structure 1 (calculated according to the recommended dose for human and the metabolic conversion ratio between human and rat 6.2). The experimental period was nine weeks, the experimental group was fed high calorie feed for five weeks, tube-fed with the film-coated structure 1 of the present invention from the sixth week, and all rats were sacrificed after the test period (nine weeks of high calorie feed) to perform analyses of body weight, food intake, body fat mass, serum biochemical mass, and liver lipid.
Rats used in this experiment were initially weighing approximately 188 grams and were fed a high calorie diet for 9 weeks. The mean body weight of the final high calorie diet + CMC group was 618.5 + -57.1 g, and the mean body weight of the control group was 477.9 + -42.0 g. Rats in the high caloric feed + CMC group gained 29.4% weight compared to the control group. The average body fat mass (adipose tissues around the epididymis, around the kidney and above the mesentery) of the high calorie feed + CMC group was 46.3 + -12.2 g, and the average body fat percentage was 7.4 + -1.4%; compared with the control group, the average body fat amount of the control group is 13.0 +/-3.0 g, the average body fat rate is 2.7 +/-0.5%, the body fat amount of the high calorie feed and CMC group is increased by 256%, and the high calorie feed obviously increases the accumulation of the body fat of rats.
After the high calorie feed was fed for 5 weeks, the group of high calorie feed + 1-fold dose, 2-fold dose and 4-fold dose was administered daily to the film-coated structure 1 for 4 weeks. Calculated from data of feeding high calorie feed for 9 weeks, the average body weight of rats in the 1-time dose group was 569.5 + -51.3 g, the average body fat weight was 36.6 + -9.6 g, and the average body fat percentage was 6.4 + -1.1%, which were reduced by 7.9% and 20.9% respectively compared to the high calorie feed and CMC group; the average body weight of rats in the 2-fold dose group is 575.5 +/-41.6 g, the average body fat weight is 37.4 +/-9.4 g, the average body fat percentage is 6.5 +/-1.3%, and compared with the group of high-calorie feed and CMC, the body weight and the body fat amount are respectively reduced by 6.9% and 19.2%; the average body weight of rats in the 4-fold dose group was 561.9 + -37.1 g, the average body fat weight was 34.8 + -8.6 g, and the average body fat percentage was 6.2 + -1.2%, which were reduced by 9.2% and 24.6% respectively compared to the high calorie feed + CMC group.
Animal experiment results show that the fat accumulation and the body fat rate induced by high-heat feed can be obviously reduced by using 1 time of the human body recommended amount of the film-coated structure 1 of the utility model for rats.
The above description is of the preferred embodiment of the present invention and the technical principles applied thereto, and it will be apparent to those skilled in the art that any changes and modifications based on the equivalent changes and simple substitutions of the technical solution of the present invention are within the protection scope of the present invention without departing from the spirit and scope of the present invention.

Claims (8)

1. A film-clad structure, comprising:
a core body including a plurality of particles, a portion of the plurality of particles forming a concave-convex outer surface on an outer side of the core body; and
the film layer comprises a concave-convex inner surface attached to the concave-convex outer surface, a plurality of first parts and a plurality of second parts with the thickness smaller than that of one first part, at least one gap is enclosed between the concave-convex outer surface and the concave-convex inner surface, and each gap at least partially corresponds to one first part.
2. The film-coating structure of claim 1 wherein the concave-convex outer surface comprises a plurality of protrusions and the concave-convex inner surface comprises a plurality of recesses correspondingly attached to at least one of the protrusions, each recess being disposed on one of the second portions.
3. The film-cladding structure of claim 1, wherein the thickness of each first portion decreases toward a direction of a second portion.
4. The film-cladding structure of claim 1, wherein the plurality of first portions comprise at least one convex surface protruding toward the gap.
5. The film-coating structure of claim 1, wherein the core has a maximum radial dimension of between 1.2 cm and 1.8 cm.
6. The film-cladding structure of claim 1, wherein the average thickness of the film is less than the radial dimension of at least a portion of the plurality of particles.
7. The film-cladding structure of claim 1, wherein the thickness of each second portion is 0.1 to 0.6 times the thickness of one of the first portions.
8. The film-cladding structure of claim 2, wherein the thickness of each first portion decreases toward a direction of a second portion; the plurality of first portions include at least one convex surface protruding toward the gap; the core body having a maximum radial dimension of between 1.2 cm and 1.8 cm; the average thickness of the film layer is smaller than the radial dimension of at least part of the plurality of particles; the thickness of each second part is 0.1 to 0.6 times of that of one first part; the film layer has a smooth outer surface; the core body comprises a ring peripheral surface and two end surfaces which are connected with two opposite sides of the ring peripheral surface in the circumferential direction, and each end surface is an arc convex surface; the film layer is a transparent layer; the plurality of particles has at least two colors.
CN202022846522.7U 2020-12-02 2020-12-02 Film coating structure Active CN215536652U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202022846522.7U CN215536652U (en) 2020-12-02 2020-12-02 Film coating structure

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202022846522.7U CN215536652U (en) 2020-12-02 2020-12-02 Film coating structure

Publications (1)

Publication Number Publication Date
CN215536652U true CN215536652U (en) 2022-01-18

Family

ID=79815036

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202022846522.7U Active CN215536652U (en) 2020-12-02 2020-12-02 Film coating structure

Country Status (1)

Country Link
CN (1) CN215536652U (en)

Similar Documents

Publication Publication Date Title
CN102525993A (en) Delayed release tablet with defined core geometry
RU2640561C2 (en) Increase of drug bidostasticity at therapy by naltrexone
CN101091708A (en) Composition for reducing blood fat, and preparation method
CA2471766A1 (en) Compositions for improving lipid metabolism
CN215536652U (en) Film coating structure
KR20170099539A (en) Sedum composition promoting antioxidant and alcohol oxidation
JP2005325025A (en) Diabetes-preventing/treating composition
CN101224202A (en) Weight reducing compound
CN102150838A (en) Weight losing composition, preparation containing same and preparation method thereof
EP3165221B1 (en) Blood-fat reducing composition and application thereof
Visioli et al. Prevention and treatment of atherosclerosis: the use of nutraceuticals and functional foods
CN107787191B (en) Composition for weight loss comprising a beverage and beads
CN106822097A (en) A kind of pharmaceutical composition containing orlistat for losing weight
CN104127391A (en) Solid pharmaceutical composition containing atorvastatin calcium
CN101766594A (en) Officinal composition for lowering blood fat
WO2019100843A1 (en) Enteromorpha prolifera polysaccharide composite blood lipid-lowering health care product and preparation method therefor
CN215536656U (en) Film coating structure
CN102462743B (en) Chinese medicine composition with auxiliary protection action on chemical hepatic injury as well as preparation method and application thereof
CN100363017C (en) Fat-reducing compound preparation
WO2005105095A1 (en) The combination for treating hyperlipemia
JP3225689U (en) Oral tablets
TWM593865U (en) Oral tablet
CN101720936A (en) Alkali food and preparation process thereof
CN106562937A (en) Coenzyme Q10 soft capsule and preparation method thereof
CN108619283B (en) A composition for improving lipid metabolism and reducing visceral fat

Legal Events

Date Code Title Description
GR01 Patent grant
GR01 Patent grant